glp-1 multiple endocrine neoplasia Research Reveals Potential Risks of Popular Medications for Some with Neuroendocrine Cancer Implications of GLP-1 Receptor Agonist

& Kosek, J

An over the counter medication for weight loss is a drug the FDA has approved for direct-to-consumer sale, without a prescription

The level of insulin resistance is much greater for type 2 diabetics with overweight/obesity than it is for people with overweight/obesity that have lower mean and fasting glucose levels

Treatment options like light therapy, medications, and sometimes surgery can help achieve repigmentation

Head-to-head studies show people on tirzepatide lost an average 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks

Menopausal women often see faster initial results because semaglutide directly counters the metabolic slowdown estrogen withdrawal creates